Immune effector cell associated neurotoxicity syndrome in chimeric antigen receptor-T cell therapy

Chimeric antigen receptor (CAR)-T cell therapy is an emerging staple in the treatment of certain hematological malignancies. While CAR-T cells have produced robust responses in certain hematological malignancies, toxicities associated with the therapy have limited their use. Immune Effector Cell Ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Sterner, Robert C., Sterner, Rosalie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445841/
https://www.ncbi.nlm.nih.gov/pubmed/36081506
http://dx.doi.org/10.3389/fimmu.2022.879608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445841/
https://www.ncbi.nlm.nih.gov/pubmed/36081506
http://dx.doi.org/10.3389/fimmu.2022.879608

Ejemplares similares